Key result
NAFLD linked to higher CVD and type 2 diabetes risk independent of obesity.
Answers are grounded in this paper and cite their sources.
Although the epidemic of obesity has been accompanied by an increase in the prevalence of the metabolic syndrome, not all obese develop the syndrome and even lean individuals can be insulin resistant. Both lean and obese insulin resistant individuals have an excess of fat in the liver which is not attributable to alcohol or other known causes of liver disease, a condition defined as nonalcoholic fatty liver disease (NAFLD) by gastroenterologists. The fatty liver is insulin resistant. Liver fat is highly significantly and linearly correlated with all components of the metabolic syndrome independent of obesity. Overproduction of glucose, VLDL, CRP, and coagulation factors by the fatty liver could contribute to the excess risk of cardiovascular disease associated with the metabolic syndrome and NAFLD. Both of the latter conditions also increase the risk of type 2 diabetes and advanced liver disease. The reason why some deposit fat in the liver whereas others do not is poorly understood. Individuals with a fatty liver are more likely to have excess intraabdominal fat and inflammatory changes in adipose tissue. Intervention studies have shown that liver fat can be decreased by weight loss, PPARgamma agonists, and insulin therapy.
No takes yet. Share an insight, caveat, or question.
Kotronen et al. (2007) conducted a review in Nonalcoholic fatty liver disease (NAFLD). Nonalcoholic fatty liver disease was evaluated. Nonalcoholic fatty liver disease is highly correlated with metabolic syndrome independent of obesity and increases the risk of cardiovascular disease and type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: